CVS Health Corporation
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsCVS Health is a diversified health solutions company integrating pharmacy benefit management, retail pharmacy, and health insurance through its Aetna operations.
What they do
CVS Health operates four segments: Health Care Benefits (Aetna insurance products), Health Services (CVS Caremark PBM, specialty pharmacy, and care delivery including Signify Health and Oak Street Health), Pharmacy & Consumer Wellness (retail pharmacies and clinics), and Corporate/Other. It serves approximately 87 million PBM plan members and over 37 million insurance members through about 9,000 retail locations and more than 1,000 clinics.
Revenue drivers
- Health Services (PBM) — Pharmacy benefit management, formulary management, and specialty pharmacy services generate significant product and service revenues.
- Pharmacy & Consumer Wellness — Retail prescription dispensing, vaccinations, and health and wellness merchandise sales in approximately 9,000 locations.
- Health Care Benefits (Aetna) — Premiums from medical, pharmacy, dental, Medicare Advantage, Medicare Part D, and Medicaid plans.
- Corporate/Other — Minimal operating contribution; includes legacy products and administrative expenses.
Recent performance
For Q2 2026, total revenues were $106.1 billion, up 7.3% year-over-year. GAAP diluted EPS was $2.31, up from $0.80 in Q2 2025, and Adjusted EPS rose to $2.58 from $1.81. Operating income increased 97.5% to $4.7 billion, partly due to the absence of $833 million in legacy litigation charges. Year-to-date cash flow from operations was $10.6 billion. Revenue growth was driven by all segments.
Strategy
CVS is focused on simplifying health care through a technology-powered, integrated model. Priorities include executing the Health Care Benefits margin recovery plan, expanding GLP-1 support across pharmacy and clinic offerings, and deploying agentic AI to improve customer experience. The company is also leveraging its PBM and care delivery assets to lower costs and improve outcomes.
Risks
- Medical cost trends — Elevated health care costs could pressure the Health Care Benefits segment's margins and require further pricing actions.
- Competitive pressure — Each segment operates in highly competitive markets, which could impact pricing and market share.
- Regulatory and public perception — Negative industry perception or regulatory changes could affect operations, particularly in pharmacy benefits and insurance.
- Forecast accuracy — Inability to accurately forecast benefit costs could lead to underwriting losses and financial volatility.
Outlook
Management raised full-year 2026 guidance: GAAP diluted EPS to $6.84-$7.04 (from $6.24-$6.44) and Adjusted EPS to $7.90-$8.10 (from $7.30-$7.50). Cash flow from operations guidance increased to at least $11.5 billion (from at least $9.5 billion). The company remains cautious about elevated cost trends and macro headwinds for the remainder of the year.